A new round of COVID-19 boosters could be available in the U.S as early as next week. That's when the CDC's independent panel of advisors is set to meet to recommend who will be eligible for the shots. Meanwhile, the FDA is also likely to approve the shots, which aim to protect against severe disease and death from currently circulating variants